Oncocross온코크로스
382150 · KOSDAQ · ₩382150 · 온코크로스
₩3,145▲ ₩35 (1.13%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Gross margin | — | — | 67.3% | 4.9% |
| Operating margin | −2,474.3% | −2,383.0% | −649.6% | −7,440.6% |
| Net margin | −1,653.2% | −2,410.2% | −604.7% | −4,604.7% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue growth | +6.8% | −65.4% | +1,071.5% | — |
| Operating income growth | −10.8% | −26.8% | −2.3% | — |
| Net income growth | +26.8% | −37.7% | −53.8% | — |
Returns
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Return on equity | −48.6% | −52.8% | −35.1% | −25.6% |
| Return on assets | −12.7% | −34.7% | −32.3% | −24.0% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Liabilities to equity | 138.3% | 116.5% | 10.2% | 6.7% |
| Net debt to equity | −99.4% | −111.3% | −71.9% | −96.4% |
| Current ratio | 143.6% | 420.8% | 1,141.5% | 1,525.3% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Oncocross / 온코크로스 / 382150 / KRX:382150
Source: KRX statistical information